m+Medelevator.RU
← Поиск публикаций
Revista de gastroenterologia de Mexico (English) · 2025

Descriptive study on the use of colonoscopy as a screening method for colorectal cancer.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Jabif F E, Cherne P N, Pintos C, Pollán J A, Murujosa A

Аннотация

INTRODUCTION AND AIMS: The aim of this study was to estimate the number of patients diagnosed with colorectal cancer (CRC) that underwent their first screening colonoscopy and to describe the endoscopic and anatomopathologic findings and characteristics of the patients that had a screening colonoscopy for CRC.

MATERIALS AND METHODS: A cross-sectional study was conducted that included patients aged 50 to 79 years, with prepaid healthcare at a tertiary care hospital, that underwent a first colonoscopy within the time frame of 2013 and 2022. The demographic data, endoscopic findings, and biopsy results were collected. Patients with a history of previous colonoscopy or a previous CRC diagnosis were excluded. Descriptive statistics were utilized for the data analysis.

RESULTS: Of 28,286 colonoscopies performed, 19,222 (68%) were for CRC screening. Mean patient age was 61 years, with a predominance of women (59.5%). The prevalence of CRC diagnosis was 0.6% and the most common findings were polyps (36.7%) and diverticula (35.5%). A total of 118 cases of CRC were diagnosed, as a result of the first colonoscopy. The post-colonoscopy hospitalization rate was 1.14%.

CONCLUSIONS: This study provides relevant information on the characteristics of the population undergoing CRC screening at our center. Our data contribute to having a better understanding of the profile of patients that access screening and provides a solid descriptive base through which clinical practices, diagnostic method quality, and screening program results can be evaluated.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты